Drug intelligence / Profile preview

Tricilest

Development stage
Phase 4
Lead developer
Johnson & Johnson
Modality
Small Molecules
Administration
Oral
01

Overview

Tricilest is a triphasic oral contraceptive pill developed by Janssen-Cilag, specifically marketed in Thailand. It consists of a combination of the synthetic estrogen ethinyl estradiol and the progestin norgestimate. As a hormonal combination therapy, it is indicated for the prevention of pregnancy and the treatment of mild to moderate acne vulgaris in women who also require contraception. The mechanism of action involves the suppression of gonadotropins (FSH and LH), which inhibits ovulation, and the modulation of androgen levels. By increasing sex hormone-binding globulin (SHBG) and decreasing free testosterone, Tricilest reduces sebum production, a key factor in the pathogenesis of acne.

Brand names
Tricilest
Other names
Ethinyl estradiol + norgestimateEE/NGM
02

Targets

ER (Estrogen receptor)AR (Adrenergic receptors)PR (Progesterone receptor)

Beyond the preview

Go deeper on Tricilest.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tricilest.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call